Related Articles
Screening for serum biomarkers in patients with chronic hepatitis B with hepatitis B surface antigen seroclearance, following pegylated interferon alpha therapy
Effect of entecavir in the treatment of patients with hepatitis B virus‑related compensated and decompensated cirrhosis
HBV infection suppresses the expression of inflammatory macrophage miR‑210
Anti‑HBV effect of interferon‑thymosin α1 recombinant proteins in transgenic Dunaliella salina in vitro and in vivo
Chronic hepatitis B patients with high liver fibrosis levels should receive antiviral treatment